Doble Brett, Payne Rupert, Harshfield Amelia, Wilson Edward C F
Cambridge Centre for Health Services Research, University of Cambridge, Cambridge, UK.
Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
BMJ Open. 2017 Dec 4;7(12):e019382. doi: 10.1136/bmjopen-2017-019382.
To investigate patterns of early repeat prescriptions and treatment switching over an 11-year period to estimate differences in the cost of medication wastage, dispensing fees and prescriber time for short (<60 days) and long (≥60 days) prescription lengths from the perspective of the National Health Service in the UK.
Retrospective, multiple cohort study of primary care prescriptions from the Clinical Practice Research Datalink.
Five random samples of 50 000 patients each prescribed oral drugs for (1) glucose control in type 2 diabetes mellitus (T2DM); (2) hypertension in T2DM; (3) statins (lipid management) in T2DM; (4) secondary prevention of myocardial infarction; and (5) depression.
The volume of medication wastage from early repeat prescriptions and three other types of treatment switches was quantified and costed. Dispensing fees and prescriber time were also determined. Total unnecessary costs (TUC; cost of medication wastage, dispensing fees and prescriber time) associated with <60 day and ≥60 day prescriptions, standardised to a 120-day period, were then compared.
Longer prescription lengths were associated with more medication waste per prescription. However, when including dispensing fees and prescriber time, longer prescription lengths resulted in lower TUC. This finding was consistent across all five cohorts. Savings ranged from £8.38 to £12.06 per prescription per 120 days if a single long prescription was issued instead of multiple short prescriptions. Prescriber time costs accounted for the largest component of TUC.
Shorter prescription lengths could potentially reduce medication wastage, but they may also increase dispensing fees and/or the time burden of issuing prescriptions.
调查11年间早期重复处方和治疗转换模式,从英国国家医疗服务体系的角度估计短疗程(<60天)和长疗程(≥60天)处方在药物浪费成本、配药费和开方者时间方面的差异。
对临床实践研究数据链中的初级保健处方进行回顾性多队列研究。
五个随机样本,每个样本有50000名患者,分别开具用于(1)2型糖尿病(T2DM)血糖控制;(2)T2DM高血压;(3)T2DM他汀类药物(血脂管理);(4)心肌梗死二级预防;以及(5)抑郁症的口服药物。
对早期重复处方和其他三种治疗转换造成的药物浪费量进行量化并计算成本。还确定了配药费和开方者时间。然后比较与<60天和≥60天处方相关的总不必要成本(TUC;药物浪费成本、配药费和开方者时间),标准化为120天疗程。
处方疗程越长,每张处方的药物浪费越多。然而,将配药费和开方者时间计算在内时,较长的处方疗程导致较低的TUC。这一发现适用于所有五个队列。如果开具一张长处方而非多张短处方,每120天每张处方可节省8.38英镑至12.06英镑。开方者时间成本占TUC的最大组成部分。
较短的处方疗程可能会减少药物浪费,但也可能增加配药费和/或开方的时间负担。